Adalimumab: a new modality for Behçet's disease?
作者信息
van Laar J A M, Missotten T, van Daele P L A, Jamnitski A, Baarsma G S, van Hagen P M
出版信息
Ann Rheum Dis. 2007 Apr;66(4):565-6. doi: 10.1136/ard.2006.064279. Epub 2006 Nov 23.
Abstract
摘要
相似文献
1
Adalimumab: a new modality for Behçet's disease?阿达木单抗：治疗白塞病的一种新方法？
Ann Rheum Dis. 2007 Apr;66(4):565-6. doi: 10.1136/ard.2006.064279. Epub 2006 Nov 23.
2
Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.对于对英夫利昔单抗难治的神经白塞病患者，改用阿达木单抗是有效的。
Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S102. Epub 2010 Sep 24.
3
Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.英夫利昔单抗和阿达木单抗治疗1例重症神经白塞病患者的疗效
Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S133-4.
4
Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.英夫利昔单抗和依那西普治疗失败后，阿达木单抗成功治疗白塞病顽固性生殖器溃疡。
Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S112.
5
Adalimumab for sight-threatening uveitis in Behçet's disease.阿达木单抗用于治疗白塞病中威胁视力的葡萄膜炎。
Eye (Lond). 2007 Jun;21(6):824-5. doi: 10.1038/sj.eye.6702352. Epub 2006 Apr 7.
6
Intestinal Behçet's disease: maintenance of remission with adalimumab monotherapy.肠道白塞病：阿达木单抗单药治疗维持缓解
Inflamm Bowel Dis. 2009 Dec;15(12):1769-71. doi: 10.1002/ibd.20869. Epub 2009 Jan 28.
7
Urticaria and angioedema in a patient with Behçet's disease treated with adalimumab.用阿达木单抗治疗的白塞病患者出现荨麻疹和血管性水肿。
Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S128.
8
Successful treatment of genital ulcers with infliximab in Behcet's disease.英夫利昔单抗成功治疗白塞病生殖器溃疡
Ann Rheum Dis. 2004 Jun;63(6):744-5. doi: 10.1136/ard.2003.010975.
9
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.抗TNF治疗在白塞病管理中的应用——综述与推荐依据
Rheumatology (Oxford). 2007 May;46(5):736-41. doi: 10.1093/rheumatology/kem034. Epub 2007 Apr 2.
10
Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis.成功将阿达木单抗转换用于对英夫利昔单抗过敏的伴有严重 Behçet 病相关葡萄膜炎的患者。
Rheumatol Int. 2011 Feb;31(2):243-5. doi: 10.1007/s00296-009-1178-y. Epub 2009 Oct 9.
引用本文的文献
1
Behçet's Disease Uveitis.白塞病性葡萄膜炎
J Clin Med. 2023 May 24;12(11):3648. doi: 10.3390/jcm12113648.
2
Old and New Challenges in Uveitis Associated with Behçet's Disease.白塞病相关葡萄膜炎的新老挑战
J Clin Med. 2021 May 26;10(11):2318. doi: 10.3390/jcm10112318.
3
Parafoveal Microvascular Alterations in Ocular and Non-Ocular Behҫet's Disease Evaluated With Optical Coherence Tomography Angiography.用光学相干断层血管造影术评估眼部和非眼部贝赫切特病的旁中心区微血管改变。
Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):8. doi: 10.1167/iovs.62.3.8.
4
Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.生物制剂治疗小肠白塞病的最新进展
Curr Gastroenterol Rep. 2020 Mar 19;22(5):24. doi: 10.1007/s11894-020-00759-1.
5
Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.抗肿瘤坏死因子治疗肠白塞病。
Gut Liver. 2018 Nov 15;12(6):623-632. doi: 10.5009/gnl17462.
6
Update on the Medical Management of Gastrointestinal Behçet's Disease.胃肠道白塞病的医学管理进展
Mediators Inflamm. 2017;2017:1460491. doi: 10.1155/2017/1460491. Epub 2017 Jan 22.
7
Adalimumab for Ocular Inflammation.阿达木单抗用于眼部炎症
Ocul Immunol Inflamm. 2017 Jun;25(3):405-412. doi: 10.3109/09273948.2015.1134581. Epub 2016 Mar 22.
8
Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?肠道白塞病：一种真正的炎症性肠病还是仅仅是系统性血管炎的肠道并发症？
Yonsei Med J. 2016 Jan;57(1):22-32. doi: 10.3349/ymj.2016.57.1.22.
9
A Clinical Picture of the Visual Outcome in Adamantiades-Behçet's Disease.白塞病视觉预后的临床情况
Biomed Res Int. 2015;2015:120519. doi: 10.1155/2015/120519. Epub 2015 Oct 19.
10
Adalimumab in the management of Behçet's disease.阿达木单抗在白塞病治疗中的应用
Ther Clin Risk Manag. 2015 Apr 13;11:611-9. doi: 10.2147/TCRM.S56163. eCollection 2015.
本文引用的文献
1
[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].[白塞病与现代肿瘤坏死因子抑制药物的应用可能性]
Ned Tijdschr Geneeskd. 2006 Apr 1;150(13):705-9.
2
Adalimumab for sight-threatening uveitis in Behçet's disease.阿达木单抗用于治疗白塞病中威胁视力的葡萄膜炎。
Eye (Lond). 2007 Jun;21(6):824-5. doi: 10.1038/sj.eye.6702352. Epub 2006 Apr 7.
3
Current concepts in the etiology and treatment of Behçet disease.白塞病的病因及治疗的当前概念
Surv Ophthalmol. 2005 Jul-Aug;50(4):297-350. doi: 10.1016/j.survophthal.2005.04.009.
4
The benefit/risk profile of TNF-blocking agents: findings of a consensus panel.肿瘤坏死因子阻断剂的获益/风险状况：一个共识小组的研究结果
Semin Arthritis Rheum. 2005 Jun;34(6):819-36. doi: 10.1016/j.semarthrit.2004.11.006.
5
Anti-TNF-alpha therapy for sight threatening uveitis.用于治疗威胁视力的葡萄膜炎的抗肿瘤坏死因子-α疗法。
Br J Ophthalmol. 2005 May;89(5):533-6. doi: 10.1136/bjo.2003.037192.
6
Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.英夫利昔单抗在自身免疫性和非自身免疫性疾病中的潜在非标签使用：一项综述。
Autoimmun Rev. 2005 Mar;4(3):144-52. doi: 10.1016/j.autrev.2004.08.004.
7
Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.依那西普治疗白塞病的短期试验：一项双盲、安慰剂对照研究。
J Rheumatol. 2005 Jan;32(1):98-105.
8
Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis.肿瘤坏死因子中和策略在类风湿关节炎以外的风湿性疾病中的潜力。
Semin Arthritis Rheum. 2003 Aug;33(1):1-18. doi: 10.1053/sarh.2003.50022.
9
Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens.从白塞病患者眼部分离出的Vγ9Vδ2 T细胞可识别非肽类异戊烯焦磷酸抗原。
J Neuroimmunol. 2002 Sep;130(1-2):46-54. doi: 10.1016/s0165-5728(02)00208-4.
10
Behçet's disease.白塞病。
N Engl J Med. 1999 Oct 21;341(17):1284-91. doi: 10.1056/NEJM199910213411707.
Zotero 插件